Evidence and consequences of spectrum bias in studies of criteria for liver transplant in paracetamol hepatotoxicity

QJM: An International Journal of Medicine

Volumn 101, Issue 9, 2008, Pages 723-729

  Ding, G K A ^a,b,c   Buckley, Nick A ^a,d  

^a Canberra Hospital   (Australia)

^b CANBERRA HOSPITAL   (Australia)

^c Calvary Hospital   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PARACETAMOL;

CLINICAL DECISION MAKING; DISEASE CLASSIFICATION; DRUG OVERDOSE; EVIDENCE BASED MEDICINE; HUMAN; LIFE EXPECTANCY; LIVER FAILURE; LIVER GRAFT; LIVER TRANSPLANTATION; PRIORITY JOURNAL; PROGNOSIS; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; REVIEW; SELF POISONING; SURVIVAL RATE; SYSTEMATIC ERROR; SYSTEMATIC REVIEW; TOXIC HEPATITIS;

EID: 51049099382     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcn077     Document Type: Review

References (37)

1. Gunnell D, Murray V, Hawton K. Use of paracetamol (acetaminophen) for suicide and nonfatal poisoning: Worldwide patterns of use and misuse. Suicide Life Threat Behav 2000; 30:313-26.
2. O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97:439-45.
3. van Hoek B, de Boer J, Boudjema K, Williams R, Corsmit O, Terpstra OT. Auxiliary versus orthotopic liver transplantation for acute liver failure. EURALT Study Group. European Auxiliary Liver Transplant Registry. J Hepatol 1999; 30: 699-705.
4. Townsend E, Hawton K, Harriss L, Bale E, Bond A. Substances used in deliberate self-poisoning 1985-1997: Trends and associations with age, gender, repetition and suicide intent. Soc Psychiatry Psychiatr Epidemiol 2001; 36:228-34.
5. Buckley NA, Whyte IM, O'Connell DL, Dawson AH. Activated charcoal reduces the need for N-acetylcysteine treatment after acetaminophen (paracetamol) overdose. J Toxicol Clin Toxicol 1999; 37 753-7.
6. Murray CJL, Lopez AD, Mathers CD, Stein C. The global burden of disease 2000 project: Aims methods and data sources. Global Programme on Evidence for Health Policy Discussion Paper No. 36. 0. 2001. World Health Organization.
7. Longworth L, Bryan S. An empirical comparison of EQ-5D and SF-6D in liver transplant patients. Health Econ 2003; 12:1061-7.
8. O'Grady JG, Wendon J, Tan KC, Potter D, Cottam S, Cohen AT, et al. Liver transplantation after paracetamol overdose. Br Med J 1991; 303:221-3.
9. Bernal W, Wendon J, Rela M, Heaton N, Williams R. Use and outcome of liver transplantation in acetaminophen-induced acute liver failure. Hepatology 1998; 27:1050-5.
10. Izumi S, Langley PG, Wendon J, Ellis AJ, Pernambuco RB, Hughes RD, et al. Coagulation factor V levels as a prognostic indicator in fulminant hepatic failure. Hepatology 1996; 23:1507-11.
11. Mitchell I, Bihari D, Chang R, Wendon J, Williams R. Earlier identification of patients at risk from acetaminophen-induced acute liver failure. Crit Care Med 1998; 26:279-84.
12. Anand AC, Nightingale P, Neuberger JM. Early indicators of prognosis in fulminant hepatic failure: An assessment of the King's criteria. J Hepatol 1997; 26:62-8.
13. Mutimer DJ, Ayres RC, Neuberger JM, Davies MH, Holguin J, Buckels JA, et al. Serious paracetamol poisoning and the results of liver transplantation. Gut 1994; 35:809-14.
14. Schmidt LE, Dalhoff K. Serum phosphate is an early predictor of outcome in severe acetaminophen-induced hepatotoxicity. Hepatology 2002; 36:659-65.
15. Larsen FS, Kirkegaard P, Rasmussen A, Hansen BA. The Danish liver transplantation program and patients with serious acetaminophen intoxication. Transplant Proc 1995; 27:3519-20.
16. Schiodt FV, Bondesen S, Petersen I, Dalhoff K, Ott P, Tygstrup N. Admission levels of serum Gc-globulin: Predictive value in fulminant hepatic failure. Hepatology 1996; 23:713-8.
17. Schmidt LE, Wang LP, Hansen BA, Larsen FS. Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: A prospective controlled trial. Liver Transpl 2003; 9:290-7.
18. Schmidt LE, Ott P, Tygstrup N. Galactose elimination capacity as a prognostic marker in patients with severe acetaminophen-induced -hepatotoxicity: 10 years' experience. Clin Gastroenterol Hepatol 2004; 2: 418-24.
19. Brandsaeter B, Hockerstedt K, Friman S, Ericzon BG, Kirkegaard P, Isoniemi H, et al. Fulminant hepatic failure: Outcome after listing for highly urgent liver transplantation-12 years experience in the Nordic countries. Liver Transpl 2002; 8:1055-62.
20. Gow PJ, Smallwood RA, Angus PW. Paracetamol overdose in a liver transplantation centre: An 8-year experience. J. Gastroenterol Hepatol 1999; 14:817-21.
21. Gow PJ, Angus PW, Smallwood RA. Transplantation in patients with paracetamol-induced fulminant hepatic failure. Lancet 1997; 349 651-2.
22. Gow PJ, Sood S, Angus PW. Serum phosphate as a predictor of outcome in acetaminophen-induced fulminant hepatic failure. Hepatology 2003; 37:711-2.
23. Bernal W, Donaldson N, Wyncoll D, Wendon J. Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: A cohort study. Lancet 2002; 359:558-63.
24. Chung PY, Sitrin MD, Te HS. Serum phosphorus levels predict clinical outcome in fulminant hepatic failure. Liver Transpl 2003; 9 248-53.
25. Shakil AO, Kramer D, Mazariegos GV, Fung JJ, Rakela J. Acute liver failure: Clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl 2000; 6:163-9.
26. Watanabe FD, Shackleton CR, Cohen SM, Goldman DE, Arnaout WS, Hewitt W, et al. Treatment of acetaminophen induced fulminant hepatic failure with a bioartificial liver. Transplant Proc 1997; 29 487-8.
27. Donaldson BW, Gopinath R, Wanless IR, Phillips MJ, Cameron R, Roberts EA, et al. The role of transjugular liver biopsy in fulminant liver failure: Relation to other prognostic indicators. Hepatology 1993; 18:1370-6.
28. Ng KL, Davidson JS, Bathgate AJ. Serum phosphate is not a reliable early predictor of outcome in paracetamol induced hepatotoxicity. 2004; 10 158-9. Erratum in: Liver Transpl 2004; 10:329.
29. Makin AJ, Wendon J, Williams R. A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987-1993). Gastroenterology 1995; 109:1907-16.
30. Dabos KJ, Newsome PN, Parkinson JA, Davidson JS, Sadler IH, Plevris JN, et al. A biochemical prognostic model of outcome in paracetamol-induced acute liver injury. Transplantation 2005; 27; 80:1712-7
31. Detry O, Arkadopoulos N, Ting P, Kahaku E, Watanabe FD, Rozga J, et al. Clinical use of a bioartificial liver in the treatment of acetaminophen-induced fulminant hepatic failure. Am Surg 1999; 65:934-8.
32. Schmidt LE, Larsen FS. Prognostic implications of hyperlactatemia, multiple organ failure, and systemic inflammatory response syndrome in patients with acetaminophen-induced acute liver failure. Crit Care Med 2006; 34:337-43.
33. Larson AM, Polson J, Fontana RJ, Davern TJ, Lalani E, Hynan LS, et al Acute Liver Failure, Study Group. Acetaminophen-induced acute liver failure: Results of a United States multicenter, prospective study. Hepatology 2005; 42:1364-72.
34. Keays R, Harrison PM, Wendon JA, Forbes A, Gove C, Alexander GJ, et al. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: A prospective controlled trial. Br Med J 1991; 303:1026-9.
35. Jaeck D, Boudjema K, Audet M, Chenard-Neu MP, Simeoni U, Meyer C, et al. Auxiliary partial orthotopic liver transplantation (APOLT) in the treatment of acute liver failure. J Gastroenterol 2002; 37(Suppl. 13):88-91.
36. Lodge JP, Dasgupta D, Prasad KR, Attia M, Toogood GJ, Davies M, et al Emergency subtotal hepatectomy: A new concept for acetaminophen-induced acute liver failure: Temporary hepatic support by auxiliary orthotopic liver transplantation enables long-term success. Ann Surg 2008; 247:238-49.
37. O'Grady JG. Clinical economics review: Liver transplantation. Aliment Pharmacol Ther 1997; 11:445-51.